Mass spectrometry for glycosylation analysis of biopharmaceuticals

Author(s):
Dotz, V.; Haselberg, R.; Shubhakar, A.; Kozak, R.P.; Falck, D. (0000-0003-3908-2376); Rombouts, Y.; Reusch, D.; Somsen, G.W.; Fernandes, D.L.; Wuhrer, M. (0000-0002-0814-4995)
Published
2015
Publication type
Article / Letter to editor
BiopharmaceuticalBiosimilarCapillary electrophoresis coupled to mass spectrometry (CE-MS)GlycomicsGlycoproteomicsGlycosylation Critical Quality Attributes (GCQA)Liquid chromatography coupled to mass spectrometry (LC-MS)Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDITOF-MS)Mass spectrometryPost-translational modification
Date issued
2015-11-30
Language
English
Is part of
Trends in Analytical Chemistry (2015), Vol. 73, p. 1-9
hdl
1887/101091
doi
10.1016/j.trac.2015.04.024